Global Adrenocortical Hormones API Sales Market Report 2020
Cortical Hormone, fully called "Adrenal Cortical Hormone", are a group of steroids secreted by adrenal corticosteroids, mainly including glucocorticoids and salt corticosteroids, as well as a small amount of sex hormones, which are important hormones involved in the metabolism of sugar, fat and protein.
Leading products represented by Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Pharmaceutical Group and Xianju Pharma have occupied a leading position in the international market, and the market share of them is over 40% in the global market. The North American market is the most important consumer region, accounting for about 40% of the global total in 2019.Europe is second only to North America, accounting for less than 30% of the global market. The downstream markets for the use of corticosteroid apis are mainly injectable, oral, topical, and inhaled. Among them, oral drugs accounted for the largest proportion, accounting for nearly 50% of the market in 2019.
Market Analysis and Insights: Global Adrenocortical Hormones API Market
The global Adrenocortical Hormones API market size is projected to reach US$ 2873.7 million by 2026, from US$ 1976.3 million in 2020, at a CAGR of 6.4% during 2021-2026.
Global Adrenocortical Hormones API Scope and Market Size
The global Adrenocortical Hormones API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adrenocortical Hormones API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Adrenocortical Hormones API market is segmented into
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Segment by Application, the Adrenocortical Hormones API market is segmented into
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs
The Adrenocortical Hormones API market is analysed and market size information is provided by regions (countries). Segment by Application, the Adrenocortical Hormones API market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Adrenocortical Hormones API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Adrenocortical Hormones API business, the date to enter into the Adrenocortical Hormones API market, Adrenocortical Hormones API product introduction, recent developments, etc.
The major vendors covered:
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD
Leading products represented by Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Pharmaceutical Group and Xianju Pharma have occupied a leading position in the international market, and the market share of them is over 40% in the global market. The North American market is the most important consumer region, accounting for about 40% of the global total in 2019.Europe is second only to North America, accounting for less than 30% of the global market. The downstream markets for the use of corticosteroid apis are mainly injectable, oral, topical, and inhaled. Among them, oral drugs accounted for the largest proportion, accounting for nearly 50% of the market in 2019.
Market Analysis and Insights: Global Adrenocortical Hormones API Market
The global Adrenocortical Hormones API market size is projected to reach US$ 2873.7 million by 2026, from US$ 1976.3 million in 2020, at a CAGR of 6.4% during 2021-2026.
Global Adrenocortical Hormones API Scope and Market Size
The global Adrenocortical Hormones API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adrenocortical Hormones API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Adrenocortical Hormones API market is segmented into
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Segment by Application, the Adrenocortical Hormones API market is segmented into
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs
The Adrenocortical Hormones API market is analysed and market size information is provided by regions (countries). Segment by Application, the Adrenocortical Hormones API market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Adrenocortical Hormones API Market Share AnalysisAdrenocortical Hormones API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Adrenocortical Hormones API business, the date to enter into the Adrenocortical Hormones API market, Adrenocortical Hormones API product introduction, recent developments, etc.
The major vendors covered:
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
